No. 25-5861
Response WaivedIFP
Tags: criminal-sentencing drug-offense fentanyl misrepresentation sentencing-guidelines u-s-sentencing-commission
Key Terms:
Trademark
Trademark
Latest Conference:
2025-11-14
Question Presented (AI Summary)
Whether, under the U.S.S.G. § 2D1.1 (b)(13), a defendant's offense can be enhanced by four levels when there is no evidence of misrepresentation and when everyone knew the pills were fentanyl
Question Presented (OCR Extract)
Whether, under the U.S.S.G. § 2D1.1 (b)(13), a defendant’s offense can be enhanced by four levels, when there is no evidence that the defendant misrepresented the content of the manufactured pills and when the undisputed evidence shows that everyone knew the pills were fentanyl? i
Docket Entries
2025-11-17
Petition DENIED.
2025-10-30
DISTRIBUTED for Conference of 11/14/2025.
2025-10-28
Waiver of United States of right to respond submitted.
2025-10-28
Waiver of right of respondent United States to respond filed.
2025-10-08
Petition for a writ of certiorari and motion for leave to proceed in forma pauperis filed. (Response due November 10, 2025)
Attorneys
Julius Rucks
Faryar Farmani — Farmani, A Professional Law Corporation, Petitioner
Faryar Farmani — Farmani, A Professional Law Corporation, Petitioner
United States
D. John Sauer — Solicitor General, Respondent
D. John Sauer — Solicitor General, Respondent